Literature DB >> 25049205

CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.

Wei Cao1, Zhifeng Qiu1, Ting Zhu1, Yanling Li1, Yang Han1, Taisheng Li2.   

Abstract

BACKGROUND: Chronic hepatitis B virus (HBV) infection includes a set of heterogeneous clinical patterns, and core-protein-specific T cell response is important for virus control and disease progression, yet is not well elucidated.
OBJECTIVES: To analyze the phenotypic and functional profiles of HBV-core-protein-specific CD8+ T cells in different clinical patterns of chronic HBV infection. STUDY
DESIGN: A total of 46 HBV patients were recruited and classified according to their clinical status. CD8+ T cell responses in different patterns of chronic HBV infections were tested with flow cytometry using overlapping 15-mer peptides covering HBV core protein. Meanwhile, the CCR7/CD27 phenotypes of these CD8+ T cells were also determined.
RESULTS: Frequencies of gamma interferon (IFN-γ) positive CD8+ T cells in inactive HBV surface antigen (HBsAg) carriers in response to the core protein peptide pools were generally stronger than those of chronic HBV carriers and resolved individuals, especially with regards to peptide pool C13-C24. Moreover, phenotypic studies further highlighted the group of CD8+ CCR7-CD27+ T memory cells, which showed significantly higher levels of IFN-γ secretion in inactive HBsAg carriers than those in chronic hepatitis B patients, chronic HBV carriers and resolved individuals.
CONCLUSIONS: Core-protein-specific T cell response plays an important role in chronic HBV infection. Inactive HBsAg carriers showed a much stronger core-protein-specific cytotoxic T cell response than other types of chronically infected patients. CD8+ CCR7-CD27+ T memory lymphocytes may be crucial in the immune pathogenesis of chronic HBV infection.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  CCR7–CD27+ T memory cell; HBV core protein; Inactive HBsAg carrier; Specific T cell response

Mesh:

Substances:

Year:  2014        PMID: 25049205     DOI: 10.1016/j.jcv.2014.06.022

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  3 in total

Review 1.  CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention.

Authors:  Yan Yan; Renfang Chen; Xu Wang; Kai Hu; Lihua Huang; Mengji Lu; Qinxue Hu
Journal:  Front Cell Dev Biol       Date:  2019-10-01

2.  Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Authors:  Huimin Liu; Yuxin Li; Fangyuan Gao; Peipei Meng; Hao Yu; Tong Wu; Yang Zhou; Yuyong Jiang; Xianbo Wang
Journal:  Dis Markers       Date:  2020-12-12       Impact factor: 3.434

3.  Hepatitis B virus S gene therapy with 10-23 DNAzyme delivered by chitosan-g-stearic acid micelles.

Authors:  Yun Hong; Dongsen Mao; Rui Wu; Zhe Gao; Tingting Meng; Rongrong Wang; Lin Liu; Jing Miao
Journal:  RSC Adv       Date:  2019-05-15       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.